Andrew Chang, Pharm.D., Ph.D.

Co-Course Faculty for PMTO 212 Clinical Trial Drug Development in Oncology course (with Dr. Ma)

Dr. Andrew Chang is currently Executive Consultant at Lumanity where he leads development of medical affairs strategies for pharmaceutical companies. He has over 5 years of work experience in medical affairs, medical sciences, and clinical pharmacology. Dr. Chang is dual trained and completed his Doctor of Pharmacy and Doctor of Philosophy, in Cancer and Developmental Biology, at the University of California San Diego. He also completed a postgraduate fellowship in oncology and clinical pharmacology in collaboration with UC San Diego and Pfizer Inc. He provides didactic teaching in the Drug Development and Product Management (DDPM) Master’s program as well.